12:00 AM
 | 
Apr 08, 2013
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

Themis Bioscience preclinical data

In mice, a single dose of Themis' MV-CHIK vaccine provided full protection against a lethal wild-type chikungunya virus challenge...

Read the full 73 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >